Prognostic impact of soluble CD163 in patients with diffuse large Bcell lymphoma

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperComment/debate/letter to the editorResearchpeer-review

  • Heli Vajavaara, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland.
  • ,
  • Frida Ekeblad, Uppsala University and Uppsala Clinical Research Center, Uppsala University, Sweden.
  • ,
  • Harald Holte, Department of Gynaecologic Oncology, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. Institute for Cancer Genetics and Informatics, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. Faculty of Medicine, University of Oslo, Oslo, Norway.
  • ,
  • Judit Jorgensen
  • Suvi-Katri Leivonen, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland.
  • ,
  • Mattias Berglund, Uppsala University and Uppsala Clinical Research Center, Uppsala University, Sweden.
  • ,
  • Peter Kamper
  • ,
  • Holger J Moller
  • Francesco D'Amore
  • Daniel Molin, Uppsala University and Uppsala Clinical Research Center, Uppsala University, Sweden.
  • ,
  • Gunilla Enblad, Uppsala University and Uppsala Clinical Research Center, Uppsala University, Sweden.
  • ,
  • Maja Ludvigsen
  • Ingrid Glimelius, Uppsala University and Uppsala Clinical Research Center, Uppsala University, Sweden.
  • ,
  • Sirpa Leppa, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland.

Not available.

Original languageEnglish
JournalHaematologica
Volume106
Issue9
Pages (from-to)2502-2506
Number of pages5
ISSN0390-6078
DOIs
Publication statusPublished - Sep 2021

    Research areas

  • BIOMARKER, TUMOR-ASSOCIATED MACROPHAGES

See relations at Aarhus University Citationformats

ID: 217231501